Search for: "Mylan Pharmaceuticals"
Results 341 - 360
of 739
Sorted by Relevance
|
Sort by Date
1 Dec 2009, 9:45 am
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
23 Jan 2019, 9:58 am
Mylan Pharmaceuticals, Inc., et al. [read post]
23 Jan 2019, 9:58 am
Mylan Pharmaceuticals, Inc., et al. [read post]
18 Jun 2019, 11:31 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
7 Sep 2016, 5:59 am
[DealBook / New York Times] * Not only is New York Attorney General Eric Schneiderman breathing antitrust accusations down EpiPen-maker Mylan Pharmaceutical's neck, but now a proposed class-action lawsuit has been filed against the company with allegations that its "unconscionable ... price gouging" violated Ohio's consumer protection laws. [read post]
13 Sep 2017, 7:44 am
Mylan Pharmaceuticals, Inc., 1-17-cv-00379 (DED September 11, 2017, Order) (Stark, USDJ) [read post]
22 Dec 2016, 7:49 am
The defendant drug makers include: Mylan, Teva Pharmaceuticals, Citron Pharma, Heritage Pharmaceuticals, Aurobindo Pharmaceuticals, and Mayne Pharmaceuticals. [read post]
20 Oct 2009, 8:27 am
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 On October 19, 2009, the Department of Justice announced that four pharmaceutical manufacturers, Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals, and Ortho McNeil Pharmaceutical settled… [read post]
5 Nov 2006, 8:29 pm
KV Pharmaceutical Uniretic--Schwarz Pharma v. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
3 Sep 2008, 11:00 am
Mylan Pharmaceuticals, No. 1:08cv85, slip op. [read post]
18 Jul 2011, 8:21 am
Mylan, Takeda v. [read post]
25 Mar 2011, 11:43 am
Mylan Pharmaceuticals, Inc., 696 F.Supp.2d 599 (N.D.W. [read post]
27 Sep 2020, 6:36 pm
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
31 Aug 2010, 10:01 pm
(Spicy IP) India: DIPP discussion paper on compulsory licensing in the Indian Pharmaceutical sector: An ‘acquired’ afterthought? [read post]
22 Mar 2007, 1:18 pm
But, Pfizer won in three earlier district court cases, including a case against Mylan Pharmaceuticals that was handed down just last month. [read post]
11 Aug 2010, 1:03 pm
This court does not detect a situation such as the one occurred in Mylan. [read post]
12 May 2008, 8:59 am
Product Distributed by: Mylan Pharmaceuticals, Inc. under a "Bertek" LabelTherein, we are told that this Digitek recall, at least for Bertek tablets, goes back all the way to March 2006, more than two years before the April 2008 announcements by Actavis and the FDA:Mylan Pharmaceuticals Inc. is continuing a voluntary recall of the Actavis Totowa recall of Digitek ® (digoxin tablets, USP). [read post]
3 Feb 2012, 7:12 am
Mylan, Inc. [read post]
14 Apr 2015, 8:34 pm
The Federal Circuit found that Apotex has a concrete, potentially high-value stake in obtaining a declaratory judgment, and that both Daiichi and generic manufacturer Mylan Pharmaceuticals, Inc. have a concrete, potentially high-value stake in denying Apotex that judgment and thereby delaying Apotex’s market entry. [read post]
